
About Triphase Pharmaceuticals
Triphase Pharmaceuticals was a Healthcare company based in Mysuru (India). It offers comprehensive solutions in probiotic products, animal nutrition, and ingredients. It operates on a B2B model. The company has 12 employees. Triphase Pharmaceuticals has completed 1 acquisition, including Nereus Pharmaceuticals. Its Indian entity Triphase Pharmaceuticals Private Limited reported revenue of βΉ6 Lakh. The company is recorded as dissolved. Its focus areas include Pharmaceuticals, Nutraceuticals and Probiotic Products.
Company details
Triphase Pharmaceuticals operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, nutraceuticals, and probiotic products. Offers comprehensive solutions in probiotic products, animal nutrition, and ingredients. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
- Headquarters Mysuru, India
- Employees 12
- SectorsHealthcare
- Website triphasepharma.com
- Social X Facebook
- Legal Name Triphase Pharmaceuticals Private Limited
- Date of Incorporation 01 Jun, 2006
- Jurisdiction Mysore, Karnataka, India
- Annual Revenue₹6 Lakh
FY 2022 · +233% YoY
- Net Loss-₹3.36 Cr
FY 2022 · -5572% margin
- EBITDA-₹2.30 Cr
FY 2022 · -3817% margin
- Employee Count12
- Investments & Acquisitions
Associated legal entities of Triphase Pharmaceuticals
Triphase Pharmaceuticals is associated with 2 registered companies on The Company Check; the primary company is Triphase Pharmaceuticals Private Limited. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Triphase Pharmaceuticals Private Limited CIN U73100KA2006PTC039605 | Active | 01 Jun 2006 | Mysore, Karnataka | ₹0.1 Cr | 12 | 2 | View details |
| Instapill Private Limited CIN U24230KA2007PTC042337 | Active | 02 Apr 2007 | Bangalore, Karnataka | ₹101 Cr | 161 | 7 | View details |
Board of directors of Triphase Pharmaceuticals Private Limited (Triphase Pharmaceuticals)
Triphase Pharmaceuticals Private Limited is the primary company behind Triphase Pharmaceuticals. The boards of the 2 registered companies of Triphase Pharmaceuticals currently have 7 directors; the longest-serving is Venkataraman Subramanian Iyer, appointed in 2007. 23 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkataraman Subramanian Iyer DIN 00408092 | Director | 02 Apr 2007 | 19 yrs 7 mo | Instapill Private Limited |
| Guruswamy Pendyala DIN 01880807 | Whole-time director | 28 Apr 2017 | 9 yrs 6 mo | Instapill Private Limited |
| Perumal Manoharan DIN 09072766 | Director | 02 Mar 2023 | 3 yrs 8 mo | Triphase Pharmaceuticals Private Limited |
| Aditya Desiraju DIN 01158393 | Director | 02 Mar 2023 | 3 yrs 8 mo | Triphase Pharmaceuticals Private Limited |
| Ankit Gupta DIN 08015587 | Whole-time director | 11 Feb 2025 | 1 yr 9 mo | Instapill Private Limited |
| Rajashri Santosh Kumar Ojha DIN 07058128 | Director | 11 Feb 2025 | 1 yr 9 mo | Instapill Private Limited |
| Gopakumar Gopalan Nair DIN 00092637 | Director | 11 Feb 2025 | 1 yr 9 mo | Instapill Private Limited |
Financials of Triphase Pharmaceuticals
Figures of Triphase Pharmaceuticals Private Limited, the primary company behind Triphase Pharmaceuticals, for FY 2022. Revenue was ₹6 Lakh (+233% year on year). Net loss was -₹3.36 Cr (-5572% margin). EBITDA was -₹2.30 Cr (-3817% margin). Revenue has grown at a compounded annual rate of +107% over three years and -19% over five years.
- ₹6 LakhRevenue · FY 2022 · +233% YoY
- -₹3.36 CrNet loss · -5572% margin
- -₹2.30 CrEBITDA · -3817% margin
- ₹12.5 LakhPaid-up capital
- 12Employees (provident fund records)
- +107%Revenue CAGR, 3 years
- -19%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Triphase Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Triphase Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Triphase Pharmaceuticals
Triphase Pharmaceuticals has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nereus Pharmaceuticals.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Develop therapeutics for the treatment of oncology, infectious diseases and inflammation | nereuspharm.com | San Diego, United States | 1998 | Oct 2012 | β’β’β’β’ |
Complete acquisition details for Triphase Pharmaceuticals
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
3 companies that operate in the same segment as Triphase Pharmaceuticals (Nutraceutical & Food-as-Medicine Platforms) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 55.41 M | 362 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | |||
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 56.21 M | 144 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Triphase Pharmaceuticals
Triphase Pharmaceuticals is headquartered in Mysuru, India. It is registered at Mysuru, Karnataka, India.
Triphase Pharmaceuticals has 12 employees.
The primary company behind Triphase Pharmaceuticals, Triphase Pharmaceuticals Private Limited, reported revenue of βΉ6 Lakh for FY 2022, up 233% year on year.
Triphase Pharmaceuticals operates with a B2B model, focusing on providing healthcare solutions, producing pharmaceutical products, nutraceuticals, and probiotic products. Offers comprehensive solutions in probiotic products, animal nutrition, and ingredients. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Triphase Pharmaceuticals has made 1 acquisition, including Nereus Pharmaceuticals.
Triphase Pharmaceuticals is associated with 2 legal entities: Triphase Pharmaceuticals Private Limited, Instapill Private Limited.
The legal entities of Triphase Pharmaceuticals currently have 8 directors, including Ankit Gupta, Venkataraman Subramanian Iyer, Rajashri Santosh Kumar Ojha and others.